arrow
A

Adrian Gervais

Hôpital Necker-Enfants Malades
H指数:29
被引数:4,217

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons

住院患者中血液自身抗体中和I型干扰素导致鼻咽部SARS-CoV-2病毒载量高且清除延迟

2026-01-010
PRE
Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis
2025-12-051
PRE
Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies

人类I型干扰素可保护Vero E6和ARPE-19细胞免受西尼罗河病毒的侵害,并被致病性自身抗体中和

2025-04-020
OAAI
Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons

具有或不具有中和I型干扰素的自身抗体的新型冠状病毒肺炎肺炎的重症监护病房患者的肺SARS-CoV-2负荷动力学相似

2024-11-200
PRE
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
2024-11-010
OAAI
IL-7-dependent and -independent lineages of IL-7R-dependent human T cells
2024-10-010
OAAI
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases

色素失禁是胸腺发育不良,I型ifn自身抗体和病毒性疾病的基础

2024-10-011
OAAI
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
2024-09-243
OAAI
IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant

由IKZF1功能获得变体引起的IgG4-related疾病和b细胞恶性肿瘤

2024-09-013
OAAI
Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti-Type I Interferon Antibodies

胸腺瘤和抗I型干扰素抗体患者的严重西尼罗河病毒和新型冠状病毒感染

2024-07-081
PRE
Neutralizing IFN-γ autoantibodies are rare and in HLA-DRB1*15:02 or 16:02 individuals

中和性ifn-γ 自身抗体在HLA-DRB1 * 15:02或16:02个体中很少见

2024-03-120
OAAI
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

儿童中与抗ifn-α 相关的新型冠状病毒肺炎肺炎风险高于抗ifn-ω 自身抗体

2024-01-0416
OAAI
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
Science
IF45.8
2024-01-010
OA
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Auto-abs中和I型干扰素患者的疫苗突破性低氧新型冠状病毒肺炎肺炎

2023-12-2243
OAAI
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
2023-06-2236
OAAI
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
2023-05-2020
OAAI